Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-18
2009-06-23
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S257000
Reexamination Certificate
active
07550472
ABSTRACT:
The invention relates to new pteridines which are suitable for the treatment ofrespiratory or gastrointestinal complaints or diseases,inflammatory diseases of the joints, skin or eyes,diseases of the peripheral or central nervous system orcancers, as well as pharmaceutical compositions which contain these compounds.
REFERENCES:
patent: 2940972 (1960-06-01), Roch
patent: 4560685 (1985-12-01), Roch et al.
patent: 7205408 (2007-04-01), Davies
patent: 2005/0054653 (2005-03-01), Eisenbrand et al.
patent: 2006/0116370 (2006-06-01), Dollinger et al.
patent: 2006/0116371 (2006-06-01), Martyres et al.
patent: 2006/0116373 (2006-06-01), Dollinger et al.
patent: 1233179 (1988-02-01), None
patent: 1252783 (1989-04-01), None
patent: 1337813 (1995-12-01), None
patent: 3323932 (1985-01-01), None
patent: 3445298 (1986-06-01), None
patent: 3540952 (1987-05-01), None
patent: 0134922 (1985-03-01), None
patent: 0185259 (1986-06-01), None
patent: 2143232 (1985-02-01), None
patent: 200039129 (2000-07-01), None
patent: 2003062240 (2003-07-01), None
Yamamoto, K. et al.; “Differential activity of drugs to induce emesis and pica behavior inSuncus murinus(house musk shrew) and rats”, Physiology & Behavior, 2004, pp. 151-156, 83.
Merz, et al; Synthesis of 7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and Novel Derivatives Free of Positional Isomers. Potent Inhibitors of cAMP-Specific Phosphodiesterase and of Malignant Tumor Cell Growth; Journal of Medicinal Chemistry, American Chemical Society; 1998; vol. 41 (24); pp. 4733-4743.
Doherty; Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents; Current Opinion in Chemical Biology; 1999; No. 3, pp. 466-473.
Sturton et al.; Phosphodiesterase 4 Inhibitors for the Treatment of COPD; Chest; 2002; vol. 121; pp. 192S-196S.
Vignola; PDE4 inhibitors in COPD—a more selective approach to treatment; Respiratory Medicine; 2004; vol. 98; pp. 495-503.
Dollinger Horst
Jung Birgit
Mack Juergen
Martyres Domnic
Nickolaus Peter
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Morris Michael P.
Stempel Alan R.
Ward Paul V.
LandOfFree
Substituted pteridines for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pteridines for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pteridines for the treatment of inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4121621